Investors Late Over AbbVie's Failed Shire Deal, Court Says
A pair of hedge funds missed the statute of limitations for claiming pharmaceutical company AbbVie Inc. made fraudulent statements in a proposed $54 billion tax inversion with Irish biotech company Shire,...To view the full article, register now.
Already a subscriber? Click here to view full article